Journal article icon

Journal article

Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans

Abstract:
Gold nanoparticles (GNPs) have been used in the development of novel therapies as a way of delivery of both stimulatory and tolerogenic peptide cargoes. Here we report that intradermal injection of GNPs loaded with the proinsulin peptide C19-A3, in patients with type 1 diabetes, results in recruitment and retention of immune cells in the skin. These include large numbers of clonally expanded T-cells sharing the same paired T-cell receptors (TCRs) with activated phenotypes, half of which, when the TCRs were re-expressed in a cell-based system, were confirmed to be specific for either GNP or proinsulin. All the identified gold-specific clones were CD8+, whilst proinsulin-specific clones were both CD8+ and CD4+. Proinsulin-specific CD8+ clones had a distinctive cytotoxic phenotype with overexpression of granulysin (GNLY) and KIR receptors. Clonally expanded antigen-specific T cells remained in situ for months to years, with a spectrum of tissue resident memory and effector memory phenotypes. As the T-cell response is divided between targeting the gold core and the antigenic cargo, this offers a route to improving resident memory T-cells formation in response to vaccines. In addition, our scRNAseq data indicate that focusing on clonally expanded skin infiltrating T-cells recruited to intradermally injected antigen is a highly efficient method to enrich and identify antigen-specific cells. This approach has the potential to be used to monitor the intradermal delivery of antigens and nanoparticles for immune modulation in humans
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.3389/fimmu.2023.1276255
Publication website:
https://orca.cardiff.ac.uk/id/eprint/163574/1/DataSheet_1.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0002-0821-4498
More by this author
Role:
Author
ORCID:
0000-0003-1954-6305


Publisher:
Frontiers Media
Journal:
Frontiers in Immunology More from this journal
Volume:
14
Pages:
1276255-1276255
Article number:
1276255
Publication date:
2023-10-16
DOI:
EISSN:
1664-3224
ISSN:
1664-3224


Language:
English
Keywords:
Pubs id:
1561735
Local pid:
pubs:1561735
Source identifiers:
W4387670985
Deposit date:
2026-06-01
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP